These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 25988726)
1. Multifunctional envelope-type mesoporous silica nanoparticles for pH-responsive drug delivery and magnetic resonance imaging. Chen Y; Ai K; Liu J; Sun G; Yin Q; Lu L Biomaterials; 2015 Aug; 60():111-20. PubMed ID: 25988726 [TBL] [Abstract][Full Text] [Related]
2. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo. Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575 [TBL] [Abstract][Full Text] [Related]
3. Two-dimensional magnetic WS2@Fe3O4 nanocomposite with mesoporous silica coating for drug delivery and imaging-guided therapy of cancer. Yang G; Gong H; Liu T; Sun X; Cheng L; Liu Z Biomaterials; 2015 Aug; 60():62-71. PubMed ID: 25985153 [TBL] [Abstract][Full Text] [Related]
4. Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy. Li Z; Zhang L; Tang C; Yin C Pharm Res; 2017 Dec; 34(12):2829-2841. PubMed ID: 28948461 [TBL] [Abstract][Full Text] [Related]
5. Dual-targeting and pH/redox-responsive multi-layered nanocomplexes for smart co-delivery of doxorubicin and siRNA. Han L; Tang C; Yin C Biomaterials; 2015 Aug; 60():42-52. PubMed ID: 25982552 [TBL] [Abstract][Full Text] [Related]
6. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation. Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639 [TBL] [Abstract][Full Text] [Related]
7. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance. He Q; Gao Y; Zhang L; Zhang Z; Gao F; Ji X; Li Y; Shi J Biomaterials; 2011 Oct; 32(30):7711-20. PubMed ID: 21816467 [TBL] [Abstract][Full Text] [Related]
8. Molecular structural transformation regulated dynamic disordering of supramolecular vesicles as pH-responsive drug release systems. Liu Y; Gao FP; Zhang D; Fan YS; Chen XG; Wang H J Control Release; 2014 Jan; 173():140-7. PubMed ID: 24188958 [TBL] [Abstract][Full Text] [Related]
9. Thermoresponsive polymer gated and superparamagnetic nanoparticle embedded hollow mesoporous silica nanoparticles as smart multifunctional nanocarrier for targeted and controlled delivery of doxorubicin. Asghar K; Qasim M; Dharmapuri G; Das D Nanotechnology; 2020 Nov; 31(45):455604. PubMed ID: 32311684 [TBL] [Abstract][Full Text] [Related]
10. Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment. Martínez-Carmona M; Lozano D; Colilla M; Vallet-Regí M Acta Biomater; 2018 Jan; 65():393-404. PubMed ID: 29127069 [TBL] [Abstract][Full Text] [Related]
11. Rational design of multifunctional magnetic mesoporous silica nanoparticle for tumor-targeted magnetic resonance imaging and precise therapy. Chen WH; Luo GF; Lei Q; Cao FY; Fan JX; Qiu WX; Jia HZ; Hong S; Fang F; Zeng X; Zhuo RX; Zhang XZ Biomaterials; 2016 Jan; 76():87-101. PubMed ID: 26519651 [TBL] [Abstract][Full Text] [Related]
12. Multifunctional pH-sensitive superparamagnetic iron-oxide nanocomposites for targeted drug delivery and MR imaging. Zhu L; Wang D; Wei X; Zhu X; Li J; Tu C; Su Y; Wu J; Zhu B; Yan D J Control Release; 2013 Aug; 169(3):228-38. PubMed ID: 23485450 [TBL] [Abstract][Full Text] [Related]
13. Ultra-small mesoporous silica nanoparticles as efficient carriers for pH responsive releases of anti-cancer drugs. Zheng H; Tai CW; Su J; Zou X; Gao F Dalton Trans; 2015 Dec; 44(46):20186-92. PubMed ID: 26535559 [TBL] [Abstract][Full Text] [Related]
14. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles. Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819 [TBL] [Abstract][Full Text] [Related]
15. pH-controllable drug carrier with SERS activity for targeting cancer cells. Fang W; Wang Z; Zong S; Chen H; Zhu D; Zhong Y; Cui Y Biosens Bioelectron; 2014 Jul; 57():10-5. PubMed ID: 24525050 [TBL] [Abstract][Full Text] [Related]
16. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery. Ma X; Zhao Y; Ng KW; Zhao Y Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533 [TBL] [Abstract][Full Text] [Related]
17. Design of tumor-homing and pH-responsive polypeptide-doxorubicin nanoparticles with enhanced anticancer efficacy and reduced side effects. Hu J; Xie L; Zhao W; Sun M; Liu X; Gao W Chem Commun (Camb); 2015 Jul; 51(57):11405-8. PubMed ID: 26086450 [TBL] [Abstract][Full Text] [Related]
18. Dendrimerlike mesoporous silica nanoparticles as pH-responsive nanocontainers for targeted drug delivery and bioimaging. Dai L; Zhang Q; Li J; Shen X; Mu C; Cai K ACS Appl Mater Interfaces; 2015 Apr; 7(13):7357-72. PubMed ID: 25765172 [TBL] [Abstract][Full Text] [Related]
19. A facile route for rapid synthesis of hollow mesoporous silica nanoparticles as pH-responsive delivery carrier. Xu H; Zhang H; Wang D; Wu L; Liu X; Jiao Z J Colloid Interface Sci; 2015 Aug; 451():101-7. PubMed ID: 25890118 [TBL] [Abstract][Full Text] [Related]
20. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles. Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]